BDBM725013 5-(tert-butyl)-N-(4-(2-(cyclopropanecarboxamido)-5-fluoropyridin-4-yl)-2-methylbenzyl)-1,2,4-oxadiazole-3-carboxamide ::US12240838, Compound 20

SMILES Cc1cc(-c2cc(NC(=O)C3CC3)ncc2F)ccc1[C@@H](C)NC(=O)c1noc(C(C)(C)C)n1

InChI Key InChIKey=ACORGHVAQGNKNI-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 725013   

TargetTyrosine-protein kinase BTK(Human)
Biogen Ma

US Patent
LigandPNGBDBM725013(5-(tert-butyl)-N-(4-(2-(cyclopropanecarboxamido)-5...)
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/6/2025
Entry Details
US Patent